EYE National Vision Holdings, Inc.

FY2026 10-K
Filed: Mar 4, 2026
Health Care
Ophthalmic GoodsSEC EDGAR

National Vision Holdings, Inc. (EYE) filed its fiscal year 2026 10-K annual report with the SEC on Mar 4, 2026. This page provides AI-powered analysis of the filing, including business overview, management discussion, risk factors, and key financial metrics from XBRL data.

AI Filing Analysis
FY2026 10-K

Business Overview

  • Core business model: retail and managed vision care services, including eyeglasses and contact lenses sold through stores and online
  • New emphasis on remote medicine solution deployment challenged by inconsistent telehealth regulations across states
+3 more insights

Management Discussion & Analysis

  • Revenue not explicitly stated; net income from continuing ops $29.6M (1.5% margin) FY2025 vs loss $(27.2M) (–1.5%) FY2024
  • Adjusted Operating Income $102.5M (5.2% margin) FY2025 vs $65.5M (3.6%) FY2024; Adjusted EBITDA $192.9M (9.7% margin) FY2025 vs $155.5M (8.5%) FY2024
+3 more insights

Risk Factors

  • Managed care revenue concentration risk: 42% of total revenue in 2025 from few major vision care payors
  • Macroeconomic impact: reduced customer demand in 2025 due to inflation and geopolitical uncertainty affecting consumer behaviors
+3 more insights

Financial Summary
XBRL

Source: XBRL data from National Vision Holdings, Inc. FY2026 10-K filing on SEC EDGAR. All figures in USD.

Get deeper insights on National Vision Holdings, Inc.

Access full AI analysis, insider trading data, fund holdings, and cross-signal detection on SignalX.

Try Pro free for 1 month!

Enter SX-8KKYTN at checkout

Limited spots available